Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ANAB
MAZE
Add up to 3 more stocks
ANAB
AnaptysBio, Inc.
-2.24%
$48.10-1.10Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$1.42B
52W Range
$19.65 - $72.36
MAZE
Maze Therapeutics, Inc.
-1.48%
$26.04-0.39Delayed quote: Oct 6, 2026, 12:45 PM EDT
Market Cap
$1.44B
52W Range
$21.95 - $53.65
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 8.96 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 134.55 | 3.18 |
| P/S Ratio | 5.99 | 72.06 |
| P/FCF Ratio | 78.97 | N/A |
| EV/EBITDA | 11.49 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 99.0% | 0.0% |
| Operating Margin | 20.4% | 0.0% |
| Net Margin | 82.4% | -668.0% |
| ROE | 1849.1% | -29.5% |
| ROA | 61.8% | -25.1% |
| ROIC | 47.5% | -28.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.61 | 18.31 |
| Quick Ratio | 5.61 | 18.31 |
| Debt/Equity | 25.47 | 0.13 |
| Interest Coverage | 0.60 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.